BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31033488)

  • 1. Drug Repositioning in Oncology.
    Serafin MB; Bottega A; da Rosa TF; Machado CS; Foletto VS; Coelho SS; da Mota AD; Hörner R
    Am J Ther; 2021 Jan-Feb 01; 28(1):e111-e117. PubMed ID: 31033488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
    Kast RE; Karpel-Massler G; Halatsch ME
    Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
    Skaga E; Skaga IØ; Grieg Z; Sandberg CJ; Langmoen IA; Vik-Mo EO
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1495-1507. PubMed ID: 31028540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
    Halatsch ME; Kast RE; Karpel-Massler G; Mayer B; Zolk O; Schmitz B; Scheuerle A; Maier L; Bullinger L; Mayer-Steinacker R; Schmidt C; Zeiler K; Elshaer Z; Panther P; Schmelzle B; Hallmen A; Dwucet A; Siegelin MD; Westhoff MA; Beckers K; Bouche G; Heiland T
    Neurooncol Adv; 2021; 3(1):vdab075. PubMed ID: 34377985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma.
    Rauschenbach L; Wieland A; Reinartz R; Kebir S; Till A; Darkwah Oppong M; Dobersalske C; Ullrich V; Ahmad A; Jabbarli R; Pierscianek D; Fröhlich H; Simon M; Brüstle O; Sure U; Glas M; Scheffler B
    Eur J Cancer; 2020 Nov; 140():130-139. PubMed ID: 33091717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in drug repositioning for the discovery of new anticancer drugs.
    Shim JS; Liu JO
    Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
    Nunes M; Henriques Abreu M; Bartosch C; Ricardo S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
    Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
    Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
    Padhy BM; Gupta YK
    J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs-disulfiram and ritonavir.
    Kast RE
    Chin J Cancer; 2015 Apr; 34(4):161-5. PubMed ID: 25963312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs are not enough‑drug repositioning in oncology: An update.
    Armando RG; Mengual Gómez DL; Gomez DE
    Int J Oncol; 2020 Mar; 56(3):651-684. PubMed ID: 32124955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Curr Med Chem; 2021; 28(11):2137-2174. PubMed ID: 32895037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
    Kobayashi Y; Banno K; Kunitomi H; Tominaga E; Aoki D
    J Gynecol Oncol; 2019 Jan; 30(1):e10. PubMed ID: 30479094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential to treat lung cancer via inhalation of repurposed drugs.
    Lee WH; Loo CY; Ghadiri M; Leong CR; Young PM; Traini D
    Adv Drug Deliv Rev; 2018 Aug; 133():107-130. PubMed ID: 30189271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing drugs for glioblastoma: From bench to bedside.
    Basso J; Miranda A; Sousa J; Pais A; Vitorino C
    Cancer Lett; 2018 Aug; 428():173-183. PubMed ID: 29729291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of a Novel Treatment for Neurological Disorders by Drug Repositioning].
    Saito S; Ihara M
    Brain Nerve; 2019 Sep; 71(9):936-942. PubMed ID: 31506395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repositioning for rare diseases: Knowledge-based success stories.
    Scherman D; Fetro C
    Therapie; 2020 Apr; 75(2):161-167. PubMed ID: 32164975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells.
    Kast RE; Ramiro S; Lladó S; Toro S; Coveñas R; Muñoz M
    J Neurooncol; 2016 Feb; 126(3):425-31. PubMed ID: 26603162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.